Investment/Collaboration Opportunities


EUDENDRON is offering two investment/collaborations opportunities:


A) Cancer Targeted Therapies: to develop the novel EUD-GK-91 compound up to proof of concept in animal model


B) Kinase Inhibitors Platform: to transfer the successful molecular design applied in the development of EUD-GK-91 to different chemotypes to target the kinome



Eudendron S.r.l.

Legal Office:

Via Dei Carantani,1 


21100 - ITALY


P.IVA: 03303730125 

C.F.: 03303730125

REA: VA-340127


T: +39 340 3665660

    +44 7918 928462

© 2012 by Eudendron Srl. 

No animals were harmed in the making of this site.

  • facebook
  • w-tbird
  • w-googleplus
This site was designed with the
website builder. Create your website today.
Start Now